Cue Biopharma, Inc. (CUE) Financials

CUE Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2025 42.2 million 15.8 million
Sept. 30, 2025 31.6 million 18.4 million
June 30, 2025 40.7 million 22.5 million
March 31, 2025 22.3 million 15.7 million

CUE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 -1.1 million 610000
Sept. 30, 2025 -9.0 million 1.5 million
June 30, 2025 -3.4 million 1.3 million
March 31, 2025 -8.3 million 1.3 million

CUE Net Income

No data available :(

CUE Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 27.1 million - 4.2 million
Sept. 30, 2025 18.7 million - 2.7 million
June 30, 2025 28.0 million - 5.2 million
March 31, 2025 13.1 million - 3.8 million

CUE Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2025 3.7 million
Sept. 30, 2025 3.4 million
June 30, 2025 3.2 million
March 31, 2025 2.5 million

CUE Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 - 16.5 million 3.5 million -
Sept. 30, 2025 - 4.7 million 4.9 million -
June 30, 2025 27000 7.9 million 3.7 million -
March 31, 2025 150000 8.5 million 4.2 million -

CUE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 21.9 million 3.2 million
Sept. 30, 2025 2.1 million 79000
June 30, 2025 3.0 million 100000
March 31, 2025 421000 -

CUE

Price: $28.46

52 week price:
4.98
41.42

Earnings Per Share: -8.40 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 255300

Market Capitalization: 67.5 million

Links: